Trial · NCT02259088
Adverse events170
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 170
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Ranibizumab (RFB002) | 10 | 307 | |
| other | Anaemia | Blood and lymphatic system disorders | Laser | 0 | 75 | |
| other | Conjunctival haemorrhage (Study eye) | Eye disorders | Ranibizumab (RFB002) | 11 | 307 | |
| other | Conjunctival haemorrhage (Study eye) | Eye disorders | Laser | 1 | 75 | |
| other | Dry eye (Fellow eye) | Eye disorders | Ranibizumab (RFB002) | 10 | 307 | |
| other | Dry eye (Fellow eye) | Eye disorders | Laser | 1 | 75 | |
| other | Dry eye (Study eye) | Eye disorders | Ranibizumab (RFB002) | 11 | 307 | |
| other | Dry eye (Study eye) | Eye disorders | Laser | 1 | 75 | |
| other | Vitreous haemorrhage (Fellow eye) | Eye disorders | Ranibizumab (RFB002) | 11 | 307 | |
| other | Vitreous haemorrhage (Fellow eye) | Eye disorders | Laser | 3 | 75 | |
| other | Vitreous haemorrhage (Study eye) | Eye disorders | Ranibizumab (RFB002) | 5 | 307 | |
| other | Vitreous haemorrhage (Study eye) | Eye disorders | Laser | 3 | 75 | |
| other | Nasopharyngitis | Infections and infestations | Ranibizumab (RFB002) | 20 | 307 | |
| other | Nasopharyngitis | Infections and infestations | Laser | 7 | 75 | |
| other | Upper respiratory tract infection | Infections and infestations | Ranibizumab (RFB002) | 26 | 307 | |
| other | Upper respiratory tract infection | Infections and infestations | Laser | 2 | 75 | |
| other | Urinary tract infection | Infections and infestations | Ranibizumab (RFB002) | 15 | 307 | |
| other | Urinary tract infection | Infections and infestations | Laser | 3 | 75 | |
| other | Alanine aminotransferase increased | Investigations | Ranibizumab (RFB002) | 3 | 307 | |
| other | Alanine aminotransferase increased | Investigations | Laser | 4 | 75 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02259088/events